These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16999849)

  • 1. New light on an old story: von Willebrand factor binding to collagen.
    Chen J; López JA
    J Thromb Haemost; 2006 Oct; 4(10):2148-50. PubMed ID: 16999849
    [No Abstract]   [Full Text] [Related]  

  • 2. The interaction of von Willebrand factor-A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen.
    Morales LD; Martin C; Cruz MA
    J Thromb Haemost; 2006 Feb; 4(2):417-25. PubMed ID: 16420575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2M.
    Baronciani L; Federici AB; Cozzi G; Canciani MT; Mannucci PM
    J Thromb Haemost; 2006 Sep; 4(9):2088-90. PubMed ID: 16961623
    [No Abstract]   [Full Text] [Related]  

  • 4. M1761K mutation in the von Willebrand factor A3 domain associated with impaired collagen binding and without platelet dysfunction.
    Ong DM; Aumann H; Andrews RK; Gardiner EE; Rodgers SE; Davis AK
    Haemophilia; 2016 Jul; 22(4):e345-6. PubMed ID: 27354327
    [No Abstract]   [Full Text] [Related]  

  • 5. Biomedicine. Contact--how platelets touch von Willebrand factor.
    Sadler JE
    Science; 2002 Aug; 297(5584):1128-9. PubMed ID: 12183613
    [No Abstract]   [Full Text] [Related]  

  • 6. Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations.
    Rastegar-Lari G; Ajzenberg N; Ribba AS; Vereycken-Holler V; Legendre P; Villoutreix B; Meyer D; Baruch D
    Thromb Haemost; 2001 Dec; 86(6):1459-65. PubMed ID: 11776314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
    Hillery CA; Mancuso DJ; Evan Sadler J; Ponder JW; Jozwiak MA; Christopherson PA; Cox Gill J; Paul Scott J; Montgomery RR
    Blood; 1998 Mar; 91(5):1572-81. PubMed ID: 9473222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
    Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
    Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Something new about type Normandy von Willebrand disease (type 2N VWD)?
    Mazurier C
    Thromb Haemost; 2004 Jul; 92(1):1-2. PubMed ID: 15213838
    [No Abstract]   [Full Text] [Related]  

  • 10. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional studies on platelet adhesion with recombinant von Willebrand factor type 2B mutants R543Q and R543W under conditions of flow.
    Lankhof H; Damas C; Schiphorst ME; IJsseldijk MJ; Bracke M; Sixma JJ; Vink T; de Groot PG
    Blood; 1997 Apr; 89(8):2766-72. PubMed ID: 9108394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization.
    Casonato A; Pontara E; Sartorello F; Bertomoro A; Durante C; Girolami A
    J Lab Clin Med; 2001 Jan; 137(1):70-6. PubMed ID: 11150026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
    Lanke E; Kristoffersson AC; Isaksson C; Holmberg L; Lethagen S
    Eur J Haematol; 2008 Nov; 81(5):384-90. PubMed ID: 18637125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased susceptibility of von Willebrand factor to proteolysis by ADAMTS13: should the multimer profile be normal or type 2A?
    Bowen DJ
    Blood; 2004 Apr; 103(8):3246. PubMed ID: 15070714
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular modeling of ligand and mutation sites of the type A domains of human von Willebrand factor and their relevance to von Willebrand's disease.
    Jenkins PV; Pasi KJ; Perkins SJ
    Blood; 1998 Mar; 91(6):2032-44. PubMed ID: 9490688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The arginine-552-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces an abnormal folding with a loss of function resulting in type 2A-like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factor.
    Ribba AN; Hilbert L; Lavergne JM; Fressinaud E; Boyer-Neumann C; Ternisien C; Juhan-Vague I; Goudemand J; Girma J; Mazurier C; Meyer D
    Blood; 2001 Feb; 97(4):952-9. PubMed ID: 11159522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective collagen binding and increased bleeding in a murine model of von Willebrand disease affecting collagen IV binding.
    Slobodianuk TL; Kochelek C; Foeckler J; Kalloway S; Weiler H; Flood VH
    J Thromb Haemost; 2019 Jan; 17(1):63-71. PubMed ID: 30565388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A diagnosis of von Willebrand disease despite normal test results for factor VIII and von Willebrand factor antigen and activity.
    Motum P; Just S; Zebeljan D; Nicholls C; Kershaw G; Oliver S; Mohammed S; Favaloro EJ
    Am J Hematol; 2019 Dec; 94(12):1425-1432. PubMed ID: 31423628
    [No Abstract]   [Full Text] [Related]  

  • 19. Type 2M von Willebrand disease: a variant of type 2A?
    Batlle J; Pérez-Rodríguez A; Franqueira MD; López-Fernández MF
    J Thromb Haemost; 2008 Feb; 6(2):388-90. PubMed ID: 18036186
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular genetics of type 2 von Willebrand disease.
    Fressinaud E; Mazurier C; Meyer D
    Int J Hematol; 2002 Jan; 75(1):9-18. PubMed ID: 11843298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.